SPIRULINA KNOWLEDGE BASE

A randomized 2019 study reported differences in selected blood and immune measures. It did not test fresh-frozen SPRU or cancer outcomes.

A 2003 study tested isolated phycocyanin in a rat tumour-cell line. It did not test histiocytic sarcoma treatment in people.

A review of phycocyanin studies covers experimental cancer models, not proven treatment in people. Its original conclusions do not apply automatically to SPRU.

A 2021 study tested Spirulina extract in A549 and HFF cell cultures. The results are laboratory findings, not evidence of cancer treatment in people.

A 2021 review summarizes varied Spirulina and cancer-model studies. It does not show that Spirulina is a medicine or cancer treatment.

A 2022 review discusses Spirulina compounds and cancer models. The topic pages previously linked in this article are definitions, not primary studies.

A review discusses laboratory and animal studies of isolated C-phycocyanin. It says mechanisms remain unclear and does not establish clinical use.

A 2018 study tested a commercial Spirulina water extract on A549 lung-cancer cells in vitro. It did not test cancer prevention in people.

A 2017 review covers phycocyanin research in laboratory and animal models. It does not establish phycocyanin as a cancer treatment for people.